Advertisement Aoxing receives funds to improve manufacturing facility - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Aoxing receives funds to improve manufacturing facility

Aoxing Pharmaceutical's operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company has received a special funding of 2m RMB (around $315,000) from the Industry and Information Technology Department and the Finance Department of Hebei Province in China.

The funding is intended for improvements in manufacturing facility.

Aoxing Pharma Chairman and CEO Zhenjiang Yue said the company is happy for the continued support from the government of China.

Aoxing Pharmaceutical, a US incorporated specialty pharmaceutical company focuses on research, development, manufacturing and distribution of a variety of narcotics and pain-management products.